RECRUITINGOBSERVATIONAL
Treatment as Prevention for Hepatitis C in Iceland
Treatment as Prevention for Hepatitis C in Iceland. A Nationwide Campaign for Reducing Disease Burden Using Combination Antiviral Treatment
About This Trial
The main aim of this study is to test in the Icelandic population the hypothesis that a nationwide treatment program which offers effective treatment to all known cases of Hepatitis C with the aim of halting HCV (Hepatitis C virus) transmission will lead to a reduction in incidence and disease burden associated with chronic HCV infection.
Who May Be Eligible (Plain English)
Who May Qualify:
- HCV positive subjects 18 years and older, living in Iceland and covered by the Icelandic Health Insurance.
Who Should NOT Join This Trial:
- Age under 18 years
- Inability to sign willing to sign a consent form.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* HCV positive subjects 18 years and older, living in Iceland and covered by the Icelandic Health Insurance.
Exclusion Criteria:
* Age under 18 years
* Inability to sign informed consent.
Locations (1)
Landspitali
Reykjavik, Iceland